Vardhaman Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 01-06-2024
- Paid Up Capital ₹ 4.12 Cr
as on 01-06-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.07 Cr
as on 01-06-2024
- Revenue -22.14%
(FY 2017)
- Profit -18.34%
(FY 2017)
- Ebitda -18.34%
(FY 2017)
- Net Worth -1.79%
(FY 2017)
- Total Assets -2.30%
(FY 2017)
About Vardhaman Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.12 Cr.
The company has closed loans amounting to ₹0.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dayanand Naik, Umesh Patil, Sumedh Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
L85195PN1985PLC036017
- Company No.
036017
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1985
- Date of AGM
22 Mar 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vardhaman Laboratories Limited offer?
Vardhaman Laboratories Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Antiviral Drugs, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Anaemia Medicine, Revolade Tablet.
Who are the key members and board of directors at Vardhaman Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dayanand Naik  | Director | 25-Mar-2003 | Current |
| Umesh Patil | Director | 25-Mar-2003 | Current |
| Sumedh Shah | Director | 07-Dec-1993 | Current |
| Sunil Shah | Director | 07-Dec-1993 | Current |
| Dharamchand Bhikubhai | Director | 07-Dec-1993 | Current |
Financial Performance and Corporate Structure Insights of Vardhaman Laboratories.
Vardhaman Laboratories Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 22.14% decrease. The company also saw a substantial fall in profitability, with a 18.34% decrease in profit. The company's net worth dipped by a decrease of 1.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardhaman Laboratories?
In 2017, Vardhaman Laboratories had a promoter holding of 37.20% and a public holding of 62.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vardhaman Finance And Leasing Limited
Active 29 years 5 monthsSumedh Shah, Sunil Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Parshwanath Co-Op. Bank Ltd. Creation Date: 17 Nov 1992 | ₹0.70 M | Satisfied |
How Many Employees Work at Vardhaman Laboratories?
Unlock and access historical data on people associated with Vardhaman Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vardhaman Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhaman Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
